We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




First-of-Its-Kind Non-Surgical Pediatric Heart Valve to Transform Treatment of Congenital Heart Disease

By HospiMedica International staff writers
Posted on 31 Aug 2023
Print article
Image: The easy to use transcatheter pulmonary valve for young children requires only a small incision (Photo courtesy of PolyVascular)
Image: The easy to use transcatheter pulmonary valve for young children requires only a small incision (Photo courtesy of PolyVascular)

Children born with congenital heart defects often undergo a series of invasive open-heart surgeries that affect their ability to lead full lives. Now, a first-of-its-kind, non-surgical heart valve holds the promise of reducing the need for multiple procedures in young children afflicted by congenital heart disease and significantly improving their quality of life.

PolyVascular (Houston, TX, USA) is developing a next-generation heart valve replacement for children suffering from congenital heart disease. The company offers the only non-surgical pulmonary valve and delivery system suitable for children as young as two years old. PolyVascular’s minimally invasive valve minimizes the need for open heart surgeries, allowing the children to embrace a healthy and normal lifestyle. PolyVascular's biocompatible, robust, polymer-based valve overcomes the limitations inherent in current solutions wherein animal tissue valves can lead to endocarditis and human donor grafts might sensitively impact the child's immune system. Notably, the valve can be manufactured in various sizes to accommodate diverse patient needs.

The PolyVascular pulmonary valve is accompanied by an easy-to-use delivery system developed specifically for children that allows the valve percutaneously to be positioned safely. Furthermore, the stented polymer valve technology developed by PolyVascular can be scaled up to cater to larger sizes suitable for teenagers and adults, and can be expanded to explore the aortic, mitral, and tricuspid valve markets. PolyVascular is now further advancing the development of its novel polymer heart valve valve, aiming to make it clinically ready for human use. This potentially life-saving technology holds the prospect of eliminating the need for invasive surgeries in children afflicted by congenital heart disease.

Related Links:
PolyVascular 

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Oscillation & Lung Expansion Therapy System
Volara System
New
CT Detector
PURE INSIGHT

Print article

Channels

Surgical Techniques

view channel
Image: The MagDI System for side-to-side duodeno-ileal anastomosis has been granted FDA De Novo marketing authorization (Photo courtesy of GT Metabolic Solution)

Novel Magnet Compression Anastomosis Technology Ensures Fewer Complications, Bleeds or Leaks

Traditional anastomotic devices like staples or sutures can be challenging to apply in tight spaces during minimally invasive surgeries and may harm bowel tissue by cutting or piercing it, leaving foreign... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.